Tag: Heart Failure

Improvement seen in aortic function, with significantly reduced augmentation index and pulse wave velocity and increased compliance

Reduced risk seen for total hospitalizations for heart failure, total adverse events of heart failure or all-cause mortality

MACE, heart failure composite end point, cardiovascular death, and all-cause death all improved with semaglutide for patients with versus without heart failure

Older age, smoking, macroalbuminuria, microalbuminuria, previous MI, diabetes, and glycated hemoglobin predict risk

Characteristics associated with elevated CMR-modeled PCWP include hypertension, BMI, age, male sex, alcohol consumption

Surgery associated with significantly lower rate of heart failure hospitalization, all-cause mortality despite more severe disease status

Disparities still persist in follow-up rates, with largest disparities seen between Black and White patients, Medicaid dual- versus non-dual-eligible

Wearable device data could predict New York Heart Association functional class similarly to clinical measures and six-minute walk test

Global regional differences seen in patient characteristics, treatment, and outcomes